Serum phosphate modifies the vascular response to vitamin D receptor activation in chronic kidney disease (CKD) patients
- 25 March 2016
- journal article
- research article
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 26 (7) , 581-589
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Paricalcitol and Endothelial Function in Chronic Kidney Disease TrialHypertension, 2014
- A Systems Biology Preview of the Relationships Between Mineral and Metabolic Complications in Chronic Kidney DiseaseSeminars in Nephrology, 2013
- Longitudinal Analysis of Vascular Function and Biomarkers of Metabolic Bone Disorders before and after Renal TransplantationAmerican Journal of Nephrology, 2013
- Phosphate May Promote CKD Progression and Attenuate Renoprotective Effect of ACE InhibitionJournal of the American Society of Nephrology, 2011
- Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomesNephrology Dialysis Transplantation, 2011
- FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney diseaseKidney International, 2010
- Fibroblast growth factor 23 and the future of phosphorus managementCurrent Opinion in Nephrology and Hypertension, 2009
- Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the communityAtherosclerosis, 2009
- Dietary Phosphorus Acutely Impairs Endothelial FunctionJournal of the American Society of Nephrology, 2009
- Forearm reactive hyperemia and mortality in end-stage renal diseaseKidney International, 2004